Biotechnology Value Fund
Venture capital · San Francisco, California, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
15Deep-tech portfolio5 active
10Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Relay Therapeutics
69Co-investorsShare a portfolio company
Portfolio · 15 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Diagonal Therapeutics | Biotech | Active | — | — |
| Disc Medicine | Biotech | Active | — | — |
| Expedition Therapeutics | Biotech | Active | — | — |
| Foghorn Therapeutics | Biotech | Active | — | — |
| Kymera Therapeutics | Biotech | Active | — | — |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Xencor | Biotech | Public | Nov 19, 2021 | $46.1M |
| Absci | Biotech | Public | Mar 30, 2021 | $216.0M |
| Vividion Therapeutics | Biotech | Acquired | Mar 2, 2021 | $240.7M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Revolution Medicines | Biotech | Public | Nov 15, 2019 | $204.2M |
| Akero Therapeutics | Biotech | Acquired | Dec 18, 2018 | $45.5M |
| Prevail Therapeutics | Biotech | Acquired | Mar 14, 2018 | $57.0M |
| Blueprint Medicines | Biotech | Acquired | Nov 20, 2014 | $73.2M |
| Turning Point Therapeutics | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#28
Portfolio exits#11
Raises, 12 months#88
Co-investors#13
Co-investors
- Atlas VentureVenture capital6 shared
- EcoR1 CapitalVenture capital6 shared
- RA CapitalVenture capital6 shared
- Logos CapitalVenture capital5 shared
- Boxer CapitalVenture capital4 shared
- Brookside CapitalVenture capital4 shared
- Third Rock VenturesVenture capital4 shared
- Bay City CapitalVenture capital3 shared
- Frazier Healthcare PartnersVenture capital3 shared
- Gurnet Point CapitalVenture capital3 shared
Sectors
- Biotech15
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.